Insights+: Breakthrough Therapy Designation by the US FDA in 2018

Breakthrough Therapy (BT) Designation is an expedited review program introduced in Section 902 of the Food and Drug Safety and Innovation Act of 2012. The Breakthrough Designation is granted to the drugs as monotherapy or in combination with other drugs intended to treat serious or life-threatening diseases and has shown substantial improvement over available therapies…

BySenior EditorMay 8, 2019

Announcements

PharmaShots Awarded as Feedspot’s Top 50 Pharma Blog

Shots:Team PharmaShots proudly announce that we are awarded as Top 50 Pharma Blog by FeedspotWe are thankful to Feedspot for identifying our efforts and awarding us with this honor. We will continue to put our effort to provide the latest news available to our subscribersPharmaShots is a Digital News Media and Insights company that…

BySenior EditorMarch 13, 2019

INSIGHTS+

Insights+: The US FDA New Drug Approvals in 2018

1. Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC)Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC2. Helsinn's (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV)Published: 14 Feb,2018 | Tags: Helsins, fosnetupitant + palonosetron, Receives, FDA, Approval, Managing Chemotherapy-Induced Nausea and Vomiting,…

BySenior EditorMarch 4, 2019

INSIGHTS+

PharmaShots’ Most Read News of 2018

PharmaShots' Most Read News of 2018 | Top 10 Pharma News of 2018 1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology PortfolioPublished: 22 Jan, 2018 | Tags: Celgene, Acquire, Juno, Cellular, Immunotherapy, Hematology Portfolio2. Sanofi to Acquire Bioverativ for its Hemophilia ProductsPublished: 22 Jan, 2018 | Tags: Sanofi, Acquire, Bioverativ, Treat,…

BySenior EditorJanuary 2, 2019

Senior Editor

Insights+: Breakthrough Therapy Designation by the US FDA in 2018

PharmaShots Awarded as Feedspot’s Top 50 Pharma Blog

Insights+: The US FDA New Drug Approvals in 2018

PharmaShots’ Most Read News of 2018

Contact US

FOLLOW US